Martha Goldberg Aronson - Aug 5, 2022 Form 4 Insider Report for Cardiovascular Systems Inc (CSII)

Role: Director
Signature: /s/ Andrew Nick as Attorney-in-Fact for Martha Goldberg Aronson pursuant to Power of Attorney previously filed.
Stock symbol: CSII
Transactions as of: Aug 5, 2022
Transactions value $: $0
Form type: 4
Date filed: 8/9/2022, 04:18 PM
Previous filing: Jun 2, 2022
Next filing: Aug 17, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CSII	Common Stock						10K	Aug 5, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CSII	Restricted Stock Units	Award	$0	+9.06K		$0.00	9.06K	Aug 5, 2022	Common Stock	9.06K		Direct	F3
holding	CSII	Restricted Stock Units						20.8K	Aug 5, 2022	Common Stock	20.8K		Direct	F1
holding	CSII	Restricted Stock Units						2.41K	Aug 5, 2022	Common Stock	2.41K		Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership.
F2	Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment, and shall be payable in cash or shares of Company common stock on the payment date.
F3	Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership; provided, however, that the restricted stock units vest in quarterly amounts of 2,266 shares on each of September 30, 2022, December 31, 2022, March 31, 2023 and June 30, 2023.